InfuSystem Holdings, Inc. provides health care services that facilitate outpatient care for durable medical equipment manufacturers and health care providers. News for INFU commonly covers financial results, segment trends and operating updates across Patient Services and Device Solutions, including oncology, pain management, wound therapy, direct payer rentals, pump and consumable sales, and biomedical services and repair.
Company updates also address revenue cycle management, payer-network and billing efficiency initiatives, relationships with DME manufacturers, contract economics, margin performance, cash flow, guidance and management presentations at investor conferences.
InfuSystem Holdings, Inc. (NYSE American: INFU) will release its second-quarter 2020 financial results on August 13, 2020, prior to market opening. A conference call for investors is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the financial results. The call can be accessed by dialing (833) 366-1127 or via live webcast on the Company's website. InfuSystem is a national provider of infusion pumps and durable medical equipment services, serving hospitals and clinics across the U.S. and Canada.
InfuSystem Holdings, Inc. (NYSE American: INFU) announced its inclusion in the FTSE Russell 2000® Index, effective after market close on June 26, 2020. This milestone is expected to enhance the company's visibility among institutional investors, as stated by CEO Richard DiIorio. InfuSystem, a provider of infusion pumps and related support services, aims to build on its operational success and expand into new therapies. The Russell 2000® Index is a key benchmark for small-cap companies, covering a significant portion of the market.
InfuSystem, a health care service provider, will present at the Lytham Partners Virtual Investor Conference on May 20, 2020, at 1:00 p.m. ET. CEO Richard DiIorio and CFO Barry Steele will speak at the event. A webcast of the presentation can be accessed on the company’s website, with a replay available afterward. Management will also hold virtual one-on-one meetings on May 21, 2020. InfuSystem offers infusion pumps and durable medical equipment support services and operates multiple Centers of Excellence across North America. Its stock is traded under the symbol INFU.
InfuSystem Holdings reported first quarter 2020 net revenues of $21.6 million, an increase of 18% year-over-year, driven by growth in both segments. Gross profit rose 22% to $12.7 million, with a gross margin of 58.8%. The company achieved an adjusted EBITDA of $4.1 million, marking a 30% increase. The net loss improved to $(0.4 million) or $(0.02) per diluted share. Despite challenges from COVID-19, oncology billings reached record levels. However, pain management revenues declined due to elective surgery delays, impacting overall performance.